Kissei Pharmaceutical Co Stock

Kissei Pharmaceutical Co Dividend 2024

Kissei Pharmaceutical Co Dividend

86 JPY

Kissei Pharmaceutical Co Dividend yield

2.32 %

Ticker

4547.T

ISIN

JP3240600001

WKN

881370

How much dividend does Kissei Pharmaceutical Co 2024 pay?

According to the latest status from October 2024, Kissei Pharmaceutical Co paid a total of 86 JPY per share in dividends within the last 12 months. With the current Kissei Pharmaceutical Co price of 3,700 JPY, this corresponds to a dividend yield of 2.32 %. A dividend is paid times per year.

2.32 % Dividend Yield=
86 JPY Dividend
3,700 JPY Stock Price

Historical Kissei Pharmaceutical Co Dividends

A dividend is paid times per year. Last year, the payout months were April and October.

PaydateDividend
4/28/202545
10/27/202445
4/28/202441
10/28/202341
4/30/202340
10/29/202240
4/30/202228
10/29/202128
4/30/202127
10/29/202027
4/30/202026
10/27/201926
4/27/201925
10/26/201825
4/28/201824
10/27/201724
4/29/201723
10/28/201623
4/29/201622
10/28/201522
1
2
3
4

Kissei Pharmaceutical Co dividend history and estimates

In 2023, Kissei Pharmaceutical Co paid a dividend amounting to 81 JPY. Dividend means that Kissei Pharmaceutical Co distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Kissei Pharmaceutical Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Kissei Pharmaceutical Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Kissei Pharmaceutical Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Kissei Pharmaceutical Co Dividend History

DateKissei Pharmaceutical Co Dividend
2027e89.18 undefined
2026e89.02 undefined
2025e89.31 undefined
202486 undefined
202381 undefined
202268 undefined
202155 undefined
202053 undefined
201951 undefined
201849 undefined
201747 undefined
201645 undefined
201543 undefined
201441 undefined
201339 undefined
201237 undefined
201135 undefined
201033 undefined
200917 undefined
200815 undefined
200716 undefined
200626 undefined
200532 undefined

Is the Kissei Pharmaceutical Co Dividend Safe?

Kissei Pharmaceutical Co has been increasing the dividend for 15 years.

Over the past 10 years, Kissei Pharmaceutical Co has increased it by an annual 7.689 %.

Over a five-year period, the distribution increased by 11.016%.

Analysts expect a Dividend Increase of 1.907% for the current fiscal year.

Kissei Pharmaceutical Co dividend payout ratio

In 2023, Kissei Pharmaceutical Co had a payout ratio of 53.58%. The payout ratio indicates the percentage of the company's profits that Kissei Pharmaceutical Co distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Kissei Pharmaceutical Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Kissei Pharmaceutical Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Kissei Pharmaceutical Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Kissei Pharmaceutical Co Payout Ratio History

DateKissei Pharmaceutical Co Payout ratio
2027e42.46 %
2026e45.24 %
2025e39.99 %
202442.14 %
202353.58 %
202224.27 %
202148.56 %
202087.89 %
201943.47 %
201826.03 %
201729.61 %
201626.97 %
201530.25 %
201423 %
201339.63 %
201240.34 %
201147.21 %
201040.77 %
200947.03 %
200838.05 %
200762.18 %
200682.15 %
200543.58 %

Dividend Details

Understanding Kissei Pharmaceutical Co's Dividend Distributions

Kissei Pharmaceutical Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Kissei Pharmaceutical Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Kissei Pharmaceutical Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Kissei Pharmaceutical Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Kissei Pharmaceutical Co Aktienanalyse

What does Kissei Pharmaceutical Co do?

Kissei Pharmaceutical Co., Ltd. is a leading innovative company in Japan that focuses on the development and production of pharmaceuticals for various diseases. The Kissei Group consists of several companies that work together in the development and production of pharmaceuticals and other medical products. History: Kissei Pharmaceutical was founded in 1946 in Matsumoto, Japan. The company initially manufactured drugs for skin and respiratory diseases and later expanded its portfolio to include drugs for cancer and Parkinson's. Over time, Kissei Pharmaceutical has also invested in research and development and has become a key player in the global pharmaceutical industry. Business model: Kissei Pharmaceutical's business model is based on the development and marketing of innovative drugs for various diseases. The company's strategy is to focus on niche markets and invest in research and development to develop groundbreaking drugs. The company also seeks partnerships and has a strong presence in the Asian market. Divisions: Kissei Pharmaceutical is divided into various business areas, including cancer, neurological disorders, metabolic disorders, and dermatological diseases. The largest business area is oncology, where the company offers many products for the treatment of cancer. The neurology division includes products for the treatment of Parkinson's and Alzheimer's. In the field of metabolic disorders, Kissei Pharmaceutical offers drugs for the treatment of diabetes and obesity. In dermatology, the products include skincare products for various skin conditions such as eczema and psoriasis. Products: Kissei Pharmaceutical offers a wide range of pharmaceutical products for a variety of diseases. In the field of oncology, the company produces drugs such as docetaxel for breast and lung cancer, and irinotecan for colon cancer. In the field of neurological disorders, Kissei Pharmaceutical produces drugs such as levodopa for Parkinson's, and TAK-659 for cancer patients with high blood sugar levels. In the field of metabolic disorders, the company produces drugs such as insulin for the treatment of diabetes, and leptin for the treatment of obesity. In dermatology, Kissei Pharmaceutical produces drugs such as epicederm for eczema and psoriasis, and apimo for acne. Conclusion: Kissei Pharmaceutical is an innovative company in Japan that specializes in the development and production of pharmaceuticals for various diseases. The company has a strong presence in the Asian market and works closely with partners to develop new drugs. With its various business divisions and wide range of products, Kissei Pharmaceutical is a key player in the global pharmaceutical industry. Kissei Pharmaceutical Co is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Kissei Pharmaceutical Co stock

How much dividend does Kissei Pharmaceutical Co pay?

Over the past 12 months, Kissei Pharmaceutical Co paid a dividend of 86 JPY . This corresponds to a dividend yield of about 2.32 %. For the coming 12 months, Kissei Pharmaceutical Co is expected to pay a dividend of 89.31 JPY.

What is the dividend yield of Kissei Pharmaceutical Co?

The current dividend yield of Kissei Pharmaceutical Co is 2.32 %.

When does Kissei Pharmaceutical Co pay dividends?

Kissei Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kissei Pharmaceutical Co?

Kissei Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kissei Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 89.31 JPY are expected. This corresponds to a dividend yield of 2.41 %.

In which sector is Kissei Pharmaceutical Co located?

Kissei Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kissei Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kissei Pharmaceutical Co from 12/1/2024 amounting to 45 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Kissei Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Kissei Pharmaceutical Co in the year 2023?

In the year 2023, Kissei Pharmaceutical Co distributed 81 JPY as dividends.

In which currency does Kissei Pharmaceutical Co pay out the dividend?

The dividends of Kissei Pharmaceutical Co are distributed in JPY.

Andere Kennzahlen von Kissei Pharmaceutical Co

Our stock analysis for Kissei Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kissei Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.